Medetomidine Exposure in a Shifting Drug Landscape: Insights From Patient Experiences

Catherine Pressimone, Lisandra Alfaro, Ilana Hull, Raagini Jawa, Payel Roy, Jane Liebschutz, Margaret Shang

Open source

DOI
10.7326/annals-26-02480
Published
2026-09-15
Container
Annals of Internal Medicine
Publisher
American College of Physicians
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7326/annals-26-02480,
  title = {Medetomidine Exposure in a Shifting Drug Landscape: Insights From Patient Experiences},
  author = {Catherine Pressimone and Lisandra Alfaro and Ilana Hull and Raagini Jawa and Payel Roy and Jane Liebschutz and Margaret Shang},
  year = {2026},
  journal = {Annals of Internal Medicine},
  doi = {10.7326/annals-26-02480},
  url = {https://doi.org/10.7326/annals-26-02480}
}

RIS

TY  - JOUR
TI  - Medetomidine Exposure in a Shifting Drug Landscape: Insights From Patient Experiences
AU  - Catherine Pressimone
AU  - Lisandra Alfaro
AU  - Ilana Hull
AU  - Raagini Jawa
AU  - Payel Roy
AU  - Jane Liebschutz
AU  - Margaret Shang
PY  - 2026
JO  - Annals of Internal Medicine
DO  - 10.7326/annals-26-02480
UR  - https://doi.org/10.7326/annals-26-02480
ER  - 

APA

Pressimone, C., Alfaro, L., Hull, I., Jawa, R., Roy, P., Liebschutz, J., & Shang, M. (2026). Medetomidine Exposure in a Shifting Drug Landscape: Insights From Patient Experiences. Annals of Internal Medicine. https://doi.org/10.7326/annals-26-02480

Source records